SCPH NASDAQ
scPharmaceuticals Inc.
1W: +0.2%
1M: +0.9%
3M: +26.9%
1Y: +32.5%
3Y: -10.6%
5Y: -24.4%
$5.67
Last traded 2025-10-08 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$36M
+167.3% ▲
Gross Profit
$25M
+155.3% ▲
Operating Income
-$65M
-16.9% ▼
Net Income
-$85M
-55.4% ▼
EPS (Diluted)
$-1.91
-34.5% ▼
EBITDA
-$77M
-68.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $14M | $36M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +167.3% |
| Cost of Revenue | $399K | $438K | $468K | $4M | $11M |
| Gross Profit | -$399K | -$438K | -$468K | $10M | $25M |
| Gross Margin | — | — | — | 72.0% | 68.7% |
| R&D Expenses | $18M | $16M | $16M | $12M | $12M |
| SG&A Expenses | $12M | $10M | $21M | $53M | $78M |
| Operating Expenses | $30M | $26M | $36M | $65M | $90M |
| Operating Income | -$30M | -$26M | -$36M | -$55M | -$65M |
| Operating Margin | — | — | — | -407.5% | -178.3% |
| Interest Expense | $3M | $3M | $3M | $8M | $8M |
| Income Before Tax | -$32M | -$28M | -$37M | -$55M | -$85M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$32M | -$28M | -$37M | -$55M | -$85M |
| Net Margin | — | — | — | -403.2% | -234.4% |
| EPS (Diluted) | $-1.31 | $-1.02 | $-1.30 | $-1.42 | $-1.91 |
| EBITDA | -$29M | -$25M | -$33M | -$46M | -$77M |
| Shares Outstanding | 25M | 27M | 28M | 39M | 45M |